Floatz logo

DERSIMELAGON

Normal Renal Function

Tanabe Pharma America, Inc.Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Normal Renal Function cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

DERSIMELAGON is also rated in:

kidney failureDormant
CC
Indicative ·
47 / 100
View asset →
liver disorderDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →